| News Updates |
 |
Long-Acting Lenacapavir Still Delivered Effective HIV PrEP After a Year
MedPageToday | August 1, 2026
|
|
Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response
UC Davis | July 30, 2026
|
|
Biotherapeutic metabolite repairs gut damage caused by HIV infection
News Medical | July 30, 2026
|
|
Dolutegravir knocks down HIV faster than bictegravir
aidsmap | July 30, 2026
|
|
Can We Teach the Immune System to Control HIV on Its Own?
The Body | July 29, 2026
|
|
International study shows once-weekly HIV pill performs as well as daily treatment
Medical Xpress | July 30, 2026
|
|
AIDS 2026: Long-Acting Weekly Oral HIV Therapy Advances Toward Regulatory Review
Infection Control Today | July 30, 2026
|
|
AIDS 2026: Research Shows Individualized HIV Treatment Is Shaping the Future
Infection Control Today | July 29, 2026
|
|
HIV/AIDS Research, Innovation Persist Despite PEPFAR Funding Cuts
The Washington Informer | July 27, 2026
|
|
AIDS 2026: ViiV Healthcare’s 2-Drug Regimen Dovato Is As Effective As 3-Drug Regimen Biktarvy In First-Of-Its-Kind Head-To-Head Study In...
ViiV | July 27, 2026
|
|
AIDS 2026: ViiV Healthcare Highlights Positive Dovato Results and Advances Long-Acting HIV Treatment Innovation at AIDS 2026
Precedence Research | July 24, 2026
|
|
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
MERCK | July 24, 2026
|
|
Phase 3 results for hepatitis B treatment show functional cure for 1 in 5 people
Medical News Today | July 22, 2026
|
|
Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48
DrugTopics | July 22, 2026
|
|
In ongoing trials, twice-yearly HIV prevention drug saw just one case
devex | July 21, 2026
|
|
ViiV Healthcare to Present Phase Iiib Data Comparing Dovato with Biktarvy in Treatment-Naïve Adults; Alongside Insti-Powered Long-Acting...
ViiV | July 21, 2026
|
|
Announcing the NIH ARISE-HIV LAUNCH Challenge
HIV.gov | July 20, 2026
|
|
A New Strategy May Finally Put An HIV Vaccine Within Reach
Forbes | July 18, 2026
|
|
HIV and Aging: NIH Research Funding Opportunities
NIH | July 16, 2026
|
|
BioNTech advances mRNA therapeutic HIV vaccine into randomized Phase I/II trial
allsci | July 16, 2026
|
|
Experimental cell therapy delivers encouraging results for patients with rare, potentially fatal brain infection
UT MD Anderson Cancer Center | July 10, 2026
|
|
New virus catalogue reveals which pathogens pose the greatest threat
Gavi | July 6, 2026
|
|
Johns Hopkins scientists develop nose spray DNA vaccine for tuberculosis
ScienceDaily | July 4, 2026
|
|
Hefty New Study Takes on Weight Conundrum in HIV Care—and Its Answers Are Complicated
The BodyPro | July 1, 2026
|
|
Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies
Nature | June 30, 2026
|
|
New HIV vaccine shows unprecedented success in primate studies
News-Medical | June 30, 2026
|
|
JID for Clinicians: Frailty outcomes in people with HIV, immune checkpoint inhibition in chronic HBV infection and more
IDSA | June 29, 2026
|
|
A new gene editing approach shields the immune system from HIV
Fred Hutchinson Cancer Center | June 29, 2026
|
|
NIH Budget Cuts Threaten HIV Research
Think Global Health | June 26, 2026
|
|
“We Know It’s Possible”: The Future of HIV Cure Research
POZ | June 25, 2026
|
|
Federal Health Department Aims to Strengthen Clinical Research and Boost Trial Participation
POZ | June 24, 2026
|
|
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
The New England Journal of Medicine | June 24, 2026
|
|
“We Know It’s Possible” The Future of HIV Cure Research
amfAR | June 23, 2026
|
|
Supercharging T-Cells Against HIV’s Weak Spots: A New HIV Vaccine Study Reveals New Hope—and New Challenges—for Aging Patients
UNC School of Medicine / Institute for Global Health and Infectious Diseases | June 8, 2026
|
|
About HIV and the Center for Drug Evaluation and Research's role
USFDA | June 8, 2026
|
|
HIV, Brain Health Research, and How It Could Benefit Everyone
amfAR | May 28, 2026
|
|
Experimental HIV vaccine achieves a long-sought goal
Scripps Research | May 28, 2026
|
|
Broccoli compounds may help repair HIV-linked gut damage, animal study suggests
MedicalXpress | May 25, 2026
|
|
A Single Infusion Could Suppress H.I.V. for Years, Study ...
The New York Times | May 11, 2026
|
|
Future Directions for NIH HIV Research: A Look Ahead to 2026
The Journal of Infectious Diseases | May 15, 2026
|
|
University Seminar: Developing an HIV/AIDS Clinical Trials Unit in Collaboration with the Community
GWU.edu | May 21, 2026
|
|
Small study hints that revving up immune cells might help fight HIV
AP | May 12, 2026
|
|
Centers for AIDS Research (CFAR)
NIH | May 8, 2026
|
|
Advances in Immune-Based Approaches for the Cure of HIV Infection
Springer | May 2, 2026
|
|
A novel gene-therapy approach to ‘functionally cure’ HIV succeeds in some monkeys
Science Advisor | April 29, 2026
|
|
Trump Cuts Threaten to Halt Two Decades of HIV Vaccine Research
The Assembly | April 29, 2026
|
|
HIV Vaccine Research (AIDS Vaccine Research)
La Jolla Institute | April 23, 2026
|
|
Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context
NIH | April 15, 2026
|
|
UNC Researchers Demonstrate Drug’s Effectiveness in Drawing Out Dormant HIV from Immune Cells
UNC | April 10, 2026
|
|
amfAR Launches $2 Million AI-Enabled, Collaborative Study to Map the HIV Reservoir
amfAR | April 8, 2026
|
| |
|
